Alana Harris Dent

Array ( [id] => 5349941 [patent_doc_number] => 20090005302 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-01-01 [patent_title] => 'METHOD, APPARATUS, AND COMPOUND FOR EFFECTING LOCALIZED, NON-SYSTEMIC, IMMUNOGENIC TREATMENT OF CANCER' [patent_app_type] => utility [patent_app_number] => 11/774585 [patent_app_country] => US [patent_app_date] => 2007-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 9817 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0005/20090005302.pdf [firstpage_image] =>[orig_patent_app_number] => 11774585 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4745656 [patent_doc_number] => 20080090258 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'Method and composition for diagnosing endometrial cancer' [patent_app_type] => utility [patent_app_number] => 11/823848 [patent_app_country] => US [patent_app_date] => 2007-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2984 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090258.pdf [firstpage_image] =>[orig_patent_app_number] => 11823848 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6483047 [patent_doc_number] => 20100008923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-14 [patent_title] => 'Organic Compounds' [patent_app_type] => utility [patent_app_number] => 12/305427 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 16657 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0008/20100008923.pdf [firstpage_image] =>[orig_patent_app_number] => 12305427 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4759347 [patent_doc_number] => 20080311573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-18 [patent_title] => 'Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer' [patent_app_type] => utility [patent_app_number] => 11/821773 [patent_app_country] => US [patent_app_date] => 2007-06-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 47612 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0311/20080311573.pdf [firstpage_image] =>[orig_patent_app_number] => 11821773 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11772476 [patent_doc_number] => 09381228 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-07-05 [patent_title] => 'FKBP-L and uses thereof' [patent_app_type] => utility [patent_app_number] => 12/303343 [patent_app_country] => US [patent_app_date] => 2007-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 70 [patent_figures_cnt] => 75 [patent_no_of_words] => 38710 [patent_no_of_claims] => 45 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 77 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12303343 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14112 [patent_doc_number] => 07803909 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-28 [patent_title] => 'Mutated Src oncogene composition and methods' [patent_app_type] => utility [patent_app_number] => 11/811158 [patent_app_country] => US [patent_app_date] => 2007-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 14 [patent_no_of_words] => 14929 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/803/07803909.pdf [firstpage_image] =>[orig_patent_app_number] => 11811158 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4720083 [patent_doc_number] => 20080242606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-10-02 [patent_title] => 'Use of IMP3 as a Prognostic Marker for Cancer' [patent_app_type] => utility [patent_app_number] => 11/758382 [patent_app_country] => US [patent_app_date] => 2007-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 30155 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0242/20080242606.pdf [firstpage_image] =>[orig_patent_app_number] => 11758382 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5436180 [patent_doc_number] => 20090170767 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-07-02 [patent_title] => 'Soluble Endoglin Compounds for the Treatment and Prevention of Cancer' [patent_app_type] => utility [patent_app_number] => 12/227546 [patent_app_country] => US [patent_app_date] => 2007-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 19479 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0170/20090170767.pdf [firstpage_image] =>[orig_patent_app_number] => 12227546 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 101448 [patent_doc_number] => 07727534 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-01 [patent_title] => 'Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions' [patent_app_type] => utility [patent_app_number] => 11/807930 [patent_app_country] => US [patent_app_date] => 2007-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 6239 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/727/07727534.pdf [firstpage_image] =>[orig_patent_app_number] => 11807930 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4802612 [patent_doc_number] => 20080014199 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-01-17 [patent_title] => 'Assessing Cancer And Vimentin' [patent_app_type] => utility [patent_app_number] => 11/753767 [patent_app_country] => US [patent_app_date] => 2007-05-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 8939 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0014/20080014199.pdf [firstpage_image] =>[orig_patent_app_number] => 11753767 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6466790 [patent_doc_number] => 20100040574 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-18 [patent_title] => 'TREATMENT OF CANCER WITH ANTI-IL-1alpha ANTIBODIES' [patent_app_type] => utility [patent_app_number] => 12/302066 [patent_app_country] => US [patent_app_date] => 2007-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6553 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20100040574.pdf [firstpage_image] =>[orig_patent_app_number] => 12302066 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4852017 [patent_doc_number] => 20080317759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-12-25 [patent_title] => 'Therapeutic uses of factors which inhibit or neutralize MIF activity' [patent_app_type] => utility [patent_app_number] => 11/798505 [patent_app_country] => US [patent_app_date] => 2007-05-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 12182 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0317/20080317759.pdf [firstpage_image] =>[orig_patent_app_number] => 11798505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258729 [patent_doc_number] => 20070212361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'MONOCLONAL ANTIBODIES TO HUMAN HIGH MOLECULAR WEIGHT-MELANOMA ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 11/746519 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2101 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212361.pdf [firstpage_image] =>[orig_patent_app_number] => 11746519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5258729 [patent_doc_number] => 20070212361 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'MONOCLONAL ANTIBODIES TO HUMAN HIGH MOLECULAR WEIGHT-MELANOMA ASSOCIATED ANTIGEN' [patent_app_type] => utility [patent_app_number] => 11/746519 [patent_app_country] => US [patent_app_date] => 2007-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2101 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20070212361.pdf [firstpage_image] =>[orig_patent_app_number] => 11746519 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6581745 [patent_doc_number] => 20100291105 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-11-18 [patent_title] => 'AGENT FOR THE TREATMENT OF MALIGNANT DISEASES' [patent_app_type] => utility [patent_app_number] => 12/594787 [patent_app_country] => US [patent_app_date] => 2007-05-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 2924 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0291/20100291105.pdf [firstpage_image] =>[orig_patent_app_number] => 12594787 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5004546 [patent_doc_number] => 20070202114 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-08-30 [patent_title] => 'P38 MAPK PATHWAY PREDICTS ENDOCRINE-RESISTANT GROWTH OF HUMAN BREAST CANCER AND PROVIDES A NOVEL DIAGNOSTIC AND TREATMENT TARGET' [patent_app_type] => utility [patent_app_number] => 11/741762 [patent_app_country] => US [patent_app_date] => 2007-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6509 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20070202114.pdf [firstpage_image] =>[orig_patent_app_number] => 11741762 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4746161 [patent_doc_number] => 20080090763 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-04-17 [patent_title] => 'NOVEL GENE ENCODING A DNA REPAIR ENZYME AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 11/739558 [patent_app_country] => US [patent_app_date] => 2007-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 25341 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20080090763.pdf [firstpage_image] =>[orig_patent_app_number] => 11739558 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 22775 [patent_doc_number] => 07799898 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-21 [patent_title] => 'Human transferase family members and uses thereof' [patent_app_type] => utility [patent_app_number] => 11/786411 [patent_app_country] => US [patent_app_date] => 2007-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 82 [patent_figures_cnt] => 90 [patent_no_of_words] => 281534 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/799/07799898.pdf [firstpage_image] =>[orig_patent_app_number] => 11786411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5084940 [patent_doc_number] => 20070274991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-29 [patent_title] => 'Treatment of tumors expressing mutant EGF receptors' [patent_app_type] => utility [patent_app_number] => 11/729483 [patent_app_country] => US [patent_app_date] => 2007-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 13356 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0274/20070274991.pdf [firstpage_image] =>[orig_patent_app_number] => 11729483 [rel_patent_id] =>[rel_patent_doc_number] =>)